These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 7372430)

  • 21. [Time-course of plasma testosterone in patients with prostate cancer treated by endocrine therapy].
    Peyromaure M; Rebillard X; Ruffion A; Salomon L; Villers A; Soulie M;
    Prog Urol; 2008 Jan; 18(1):2-8. PubMed ID: 18342148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in the androgen levels in the ventral prostate of spontaneously hypertensive rats after castration.
    Hu M; Xin D; Chen J; Sun G; Wang Y; Na Y
    BJU Int; 2009 Aug; 104(3):406-11. PubMed ID: 19239443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Behavior of nucleotides in the liver of the rat after castration and treatment with testosterone].
    Pizzichini M; Di Stefano A; Bianciardi G; Tanganelli P; Paffetti A; Marinello E
    Boll Soc Ital Biol Sper; 1988 Mar; 64(3):265-8. PubMed ID: 3190887
    [No Abstract]   [Full Text] [Related]  

  • 24. [Primary orchiectomy in prostatic cancer].
    Johansen S; Sander S
    Tidsskr Nor Laegeforen; 1982 Sep; 102(25):1267-9. PubMed ID: 6187086
    [No Abstract]   [Full Text] [Related]  

  • 25. [Surgical castration].
    Kurihara J
    Nihon Rinsho; 2000 Jul; 58 Suppl():183-5. PubMed ID: 11022710
    [No Abstract]   [Full Text] [Related]  

  • 26. Paradigms in androgen/castrate resistant states of prostate cancer in a biomarker era.
    Bianco FJ
    Urol Oncol; 2008; 26(4):408-14. PubMed ID: 18593619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormonal predictors of prostate cancer.
    Sofikerim M; Eskicorapci S; Oruç O; Ozen H
    Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of glutathione-peroxidase (GSH-PO) in the rat ventral prostate--effect of castration and administration of testosterone.
    Murakoshi M; Ikeda R; Tagawa M; Suzuki M; Takekoshi S; Watanabe K
    Tokai J Exp Clin Med; 1997 Sep; 22(3):111-8. PubMed ID: 9618832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complete androgen blockade for prostate cancer: what went wrong?
    Laufer M; Denmeade SR; Sinibaldi VJ; Carducci MA; Eisenberger MA
    J Urol; 2000 Jul; 164(1):3-9. PubMed ID: 10840412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of sex and sex hormones on structural intestinal adaptation after massive small bowel resection in rats.
    Sukhotnik I; Shiloni E; Mogilner J; Lurie M; Hirsh M; Coran AG; Krausz MM
    J Pediatr Surg; 2005 Mar; 40(3):489-95. PubMed ID: 15793723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of cyproterone acetate in achieving castration and preventing luteinizing hormone releasing hormone analogue induced testosterone surge in patients with prostate cancer.
    Appu S; Lawrentschuk N; Grills RJ; Neerhut G
    J Urol; 2005 Jul; 174(1):140-2. PubMed ID: 15947599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of prostatic glutathione-peroxidase (GSH-PO) in the rat treated with a combination of testosterone and 17beta-estradiol.
    Murakoshi M; Ikada R; Tagawa M
    Tokai J Exp Clin Med; 2003 Jul; 28(2):45-50. PubMed ID: 14714828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of diethylstilbestrol, Leuprolelin (a luteinizing hormone-releasing hormone analog), Finasteride (a 5 alpha-reductase inhibitor), and castration on the lobar subdivisions of the rat prostate.
    Yamashita A; Hayashi N; Sugimura Y; Cunha GR; Kawamura J
    Prostate; 1996 Jul; 29(1):1-14. PubMed ID: 8685049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Androgen deprivation falls as orchiectomy rates rise after changes in reimbursement in the U.S. Medicare population.
    Weight CJ; Klein EA; Jones JS
    Cancer; 2008 May; 112(10):2195-201. PubMed ID: 18393326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in aortic endothelium ultrastructure in male rats following castration, replacement with testosterone and administration of 5alpha-reductase inhibitor.
    Lu YL; Kuang L; Zhu H; Wu H; Wang XF; Pang YP; Wang NJ; Yu DL
    Asian J Androl; 2007 Nov; 9(6):843-7. PubMed ID: 17968472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controversies in the management of advanced prostate cancer.
    Tyrrell CJ
    Br J Cancer; 1999 Jan; 79(1):146-55. PubMed ID: 10408706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subcapsular orchiectomy with intracapsular testicular prosthesis for metastatic prostate carcinoma.
    Short KL; Howerton LW; Holt H; Amin M
    Urology; 1984 Jul; 24(1):38-40. PubMed ID: 6740847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CO2 laser subcapsular orchidectomy in the treatment of metastatic prostate cancer.
    Bolton DM; Costello AJ
    Lasers Surg Med; 1994; 14(1):88-9. PubMed ID: 8127213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subcapsular orchiectomy using the CO2 laser: a new technique.
    Wishnow KI; Johnson DE
    Lasers Surg Med; 1988; 8(6):604-7. PubMed ID: 3210888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of carcinoma. Hormonal treatment and orchiectomy.
    Barnes RW
    Postgrad Med; 1969 Jun; 45(6):171 passim. PubMed ID: 5789387
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.